Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://monicatxil378094.ezblogz.com/70568846/semaglutide-a-potential-solution-for-obesity